Event Description:

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020 (Office of Inspector General). However, fewer than one in five Medicare beneficiaries with an opioid use disorder (OUD) diagnosis received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care (Klimas J, Hamilton M, et al., 2021). This no-cost learning series is a collaboration of Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs). Subject matter experts will provide strategies, interventions and targeted solutions ensuring access to MOUD treatment and facilitating the continuity of care through the continuum. Join us virtually one Friday each month, September 2023 – June 2024 at 11 a.m. CT.

A general certificate of attendance will be provided for continuing education/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification within their discipline.

For questions about the series contact: QIconnect@telligen.com

Dates & Topics:

• Session 1, September 15, 2023
  Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD
  Basics & science of addiction and screening & initiating MOUD
• Session 2, October 13, 2023
  Role of the Pharmacist in the Treatment of Patients with OUD
  Medication processes, addressing opioid adverse drug events (ADEs) and risk assessment for opioid prescribing
• Session 3, November 17, 2023 (First of two parts)
  Seamlessly Transitioning Patients on MOUD to Nursing Homes
  Discharge planning, medication reconciliation and readmission prevention
• Session 4, January 12, 2024 (Second of two parts)
  Panel Discussion Seamlessly Transitioning Patients on MOUD to Nursing Homes
  Discharge planning, medication reconciliation and readmission prevention
• Session 5, February 9, 2024 (First of two parts)
  Management of Patients on MOUD During the Nursing Home Stay
  Admissions assessment and treatment, addressing stigma and naloxone training
• Session 6, March 8, 2024 (Second of two parts)
  Panel Discussion Management of Patients on MOUD During the Nursing Home Stay
  Admissions assessment & treatment, addressing stigma, and naloxone training
• Session 7, April 12, 2024 (First of two parts)
  Sustaining Recovery for Patients on MOUD
  Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies
• Session 8, May 10, 2024 (Second of two parts)
  Panel Discussion Sustaining Recovery for Patients on MOUD
  Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies
• Session 9, June 7, 2024
  Management of Patients on MOUD: Key Takeaways and Series Wrap Up

Registration Required: Register here.

*After the event, you can request presentation slides and other resources by emailing QIConnect@telligen.com.